Evaluation of the "Grasp Site" After Peeling of Epiretinal Membranes

February 11, 2025 updated by: Prim. Prof. Dr. Oliver Findl, MBA

Evaluation of the "Grasp Site" After Peeling of Epiretinal Membranes With Different ILM Forceps - a Prospective Randomized Study

The goal of this study is to compare the novel ILM sharkskin forceps with a conventional ILM forceps utilizing iOCT assistance during surgery at this "grasp site". The main questions it aims to answer are:

  1. are there differences in grasp attempts between both forceps
  2. are there differences in Instrument tissue interactions between both forceps
  3. are there differences in postsurgical anatomical and functional outcomes at the grasp site between both forceps.

Study Overview

Status

Completed

Conditions

Detailed Description

Epiretinal membranes are a disease of the retinal surface, that may affect visual acuity acuity and cause metamorphopsia, occurring in approximately 20% of the population older than 60 years. Using vitrectomy with membrane peeling, postoperative improvement of visual acuity and metamorphopsia may be achieved in a majority of patients. The surgical method has been used for some time, the first report on the surgical method of vitrectomy with membrane peeling dates back to 1978, and since the introduction of intraoperative optical coherence tomography (iOCT), intraoperative iatrogenically induced changes in retinal tissue can be detected and correlated with postoperative changes. Our group has been able to record "stretching" of the retinal tissue using this technique and has also been able to record the rarely occurring subfoveal and extrafoveal elevations of the ellipsoidal zone due to membrane peeling. These changes did not significantly affect postoperative visual acuity in our study population but did affect the development of postoperative microscotomas. Besides "retinal stretching" during surgery, ILM peeling is shown to be another factor with association of new postoperative microscotomas. New postoperative microscotomas developed in some patients without "retinal stretching" and ILM peeling. Apart from these already known iatrogenic changes, the analysis of the "grasp site" at the "starting point" of epiretinal membrane peeling is of great interest, because at this location, grasping of the epiretinal membrane may be difficult especially in case of an adherent ERM and superficial retinal lesions may be induced.

Diaz et al. demonstrated that there are postoperative changes in the "nerve fiber layer" after ILM peeling, but in that study, no recording of instrument/tissue interactions was performed using iOCT.

The aim of this study is to compare the novel ILM sharkskin forceps with a conventional ILM forceps utilizing iOCT assistance during surgery at this "grasp site".

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vienna, Austria, 1140
        • Hanusch Hospital, Department of Ophthalmology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Idiopathic ERM
  • Sheduled surgery (vitrectomy with membrane peeling), as defined by vision loss and/or metamorphopsia
  • Age 18 and older
  • Written informed consent for participation in the study

Exclusion Criteria:

  • Macular edema due to other reasons than iERM
  • Pregnancy (pregnancy test will be performed in women of reproductive age)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ILM sharkskin forceps
Patients were operated on using an ILM forceps with a laser-modified microstructure on the branches.
grasping the epiretinal membrane at the starting location, using pinch peeling, is performed with an ILM forceps.
Active Comparator: conventional ILM forceps
Patients were operated on using a conventional ILM forceps with plain surfaces on the branches.
grasping the epiretinal membrane at the starting location, using pinch peeling, is performed with an ILM forceps.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
grasp attempts
Time Frame: during surgery
number of attemps needed for opening the epiretinal membrane during grasping
during surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
metamorphopsia
Time Frame: before and 3 months after surgery
Presence of metamorphopsia is tested with the Amsler grid and M-charts
before and 3 months after surgery
microscotomata
Time Frame: before and 3 months after surgery
New deep microscotomata is tested with microperimetry
before and 3 months after surgery
Thinning of the ganglion cell layer
Time Frame: before and 3 months after surgery
Thinning of the ganglion cell layer is assessed with optical coherence tomography
before and 3 months after surgery
Central subfield thickness
Time Frame: before and 3 months after surgery
Central subfield thickness of the macula is assessed with optical coherence tomography
before and 3 months after surgery
Best corrected distant visual acuity
Time Frame: before and 3 months after surgery
Best corrected distant visual acuity is assessed by EDTRS-charts
before and 3 months after surgery
OCT biomarkers
Time Frame: before surgery
OCT biomarkers are assessed by optical coherence tomography
before surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christoph Leisser, MD, Mein Hanusch-Krankenhaus

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 12, 2023

Primary Completion (Actual)

December 1, 2024

Study Completion (Actual)

December 1, 2024

Study Registration Dates

First Submitted

December 21, 2024

First Submitted That Met QC Criteria

December 21, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 11, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SIF

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epiretinal Membrane

Clinical Trials on ILM forceps - membrane grasping

Subscribe